Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.investorsatril.com | |
Market Cap | 46.55 Cr. | |
Enterprise Value(EV) | 65.32 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.65 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 35.97 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 19.08 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 3.10 | Calculated using Price: 59.18 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.79 Cr. | 7,865,520 Shares |
FaceValue | 10 | |
About Roopa Industries Ltd. | ||
Roopa Industries is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries. The company is a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998. |
1 Day |
|
+1.44% |
1 Week |
|
+6.71% |
1 Month |
|
+2.16% |
3 Month |
|
+24.87% |
6 Month |
|
+40.95% |
1 Year |
|
+39.52% |
2 Year |
|
+129.46% |
5 Year |
|
+439.16% |
10 Year |
|
+495.57% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 1.88 | 1.96 | 2.07 | 5.63 | 5.97 | 3.51 | 6.41 | 8.41 | 10.17 | |
Return on Capital Employed (%) | 9.25 | 10.06 | 10.27 | 6.44 | 8.63 | 8.67 | 8.06 | 10.37 | 12.73 | |
Return on Assets (%) | 0.65 | 0.68 | 0.7 | 1.68 | 1.68 | 1 | 1.69 | 2.13 | 2.56 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 9 | 9 | 9 | 10 | 10 | 11 | 12 | 13 | 14 | 15 | |
Non Curr. Liab. | 4 | 6 | 8 | 11 | 10 | 9 | 9 | 5 | 3 | 6 | |
Curr. Liab. | 13 | 10 | 11 | 15 | 16 | 19 | 26 | 31 | 40 | 38 | |
Minority Int. | |||||||||||
Equity & Liab. | 26 | 25 | 29 | 35 | 36 | 38 | 46 | 49 | 57 | 59 | |
Non Curr. Assets | 10 | 8 | 7 | 9 | 11 | 11 | 11 | 11 | 14 | 15 | |
Curr. Assets | 16 | 17 | 21 | 26 | 25 | 27 | 36 | 38 | 42 | 44 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 26 | 25 | 29 | 35 | 36 | 38 | 46 | 49 | 57 | 59 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 31 | 31 | 30 | 19 | 30 | 28 | 29 | 51 | 76 | 66 | |
Other Income | 0 | 3 | 0 | 5 | 0 | 1 | 0 | 0 | 1 | 1 | |
Total Income | 31 | 34 | 30 | 24 | 30 | 29 | 29 | 51 | 77 | 67 | |
Total Expenditure | -29 | -31 | -28 | -22 | -28 | -26 | -26 | -48 | -72 | -62 | |
PBIDT | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 5 | 5 | |
Interest | -1 | -1 | -2 | -1 | -1 | -1 | -1 | -1 | -2 | -3 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 2 | 2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 1 | 1 | -1 | -5 | 4 | 2 | -1 | 2 | 9 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 3 | -2 | 1 | 1 | 4 | -1 | |
Cash Fr. Finan. | 0 | 0 | -1 | 2 | 2 | -2 | -3 | -1 | -5 | -7 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Fri, 22 Mar 2024
Closure of Trading Window Intimation of closure of Trading Window for the quarter and year ended 31 March 2024. |
Tue, 13 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Submission of Newspaper Clippings with respect to unaudited financial results for the third quarter and nine months ended 31-12-2023. |
Mon, 12 Feb 2024
Submission Of Unaudited Financial Results And Intimation Of Outcome Of The Board Meeting Held On 12Th February 2024 Submission of unaudited financial results and intimation of outcome of Board meeting held on 12th February 2024 |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Close Above Last Week High |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |